Tuesday, December 30, 2014
Wednesday, December 24, 2014
Two weeks ago the company issued a letter to shareholders and the last paragraph started as follows.
We believe that the current stock price and market valuation of Axion Power is significantly lower than it would be if the market were taking into account the inherent worth of our technology. We believe that our stock is undervalued based on the technology's potential to save money for our customers in the transportation space by increasing gas mileage and reducing emissions. In the energy storage space, using PbC batteries to decrease payback time for solar photovoltaic farms and other renewable energy projects.
Chairman of the Board of Directors and Chief Executive Officer, Steven G. Mihaylo (through a trust) agreed to purchase 1,449,275 shares of Common Stock at a price per share of $1.38 for a total of $2,000,000.00. The agreement which was signed today is expected to be financed by December 27, 2014. In addition, Mr. Mihaylo has been granted 500,000 warrants to purchase common stock of the Company; the warrants have a five year term and a strike price of $1.38 per share. Mr. Mihaylo has agreed that for a period of two years from the date of the Sale Agreement, the Company may require him to exercise the warrants if the Company determines the exercise of the warrants is necessary for the cash needs of the Company.
I understand the issuance of stock is dilutive, but I like it when a CEO has confidence in the future of his company.
Friday, December 19, 2014
Thursday, December 18, 2014
Wednesday, December 17, 2014
Google (GOOGL) hit a new 52-week low of $497.19 before closing yesterday (02014.12.16) at $498.16 (i.e. below $500).
The GDT::Portfolio is heading in the wrong direction these days (i.e. it's approaching $0).
Wednesday, November 19, 2014
Tuesday, November 11, 2014
Thursday, November 6, 2014
Over the term of the transactions described herein, Spire expects to achieve an approximate $5 million cash benefit, all of which, if achieved, can be used to support ongoing operations and grow the business.There are approximately 9.21 million SPIR shares, $5 million is roughly $0.54 per SPIR share. SPIR closed yesterday (02014.11.05) at $0.41.
On 02014.10.31, Spire had a press release titled Spire Receives Prestigious Solar Power World Award for Leadership in Solar. In that press release Spire stated the following:
Based upon our recent activities, revenues recognized to date and expected shipments, for the remainder of 2014 we anticipate a doubling of our 2013 solar business volume and coupled with the increased level of client inquiries, we certainly feel that the forecasted demand for turnkey lines has now materialized and will extend into 2015.
SPIR closed on 02014.11.05 at $0.41. 52-week range: $0.20 - 1.17. The stock is priced as if Spire is going out of business any day now. At its current price SPIR has a Price-Sales-Ratio of 0.23 and a market value of only $3.73 million.
Wednesday, November 5, 2014
Tuesday, November 4, 2014
LVLT is an Internet-pipe investment for us. Late last month LVLT was added to the S&P 500. LVLT started today at #16 in the GDT::Portfolio. Unless personal finances dictate otherwise, I have no plans on selling any LVLT.
Monday, November 3, 2014
TWTR closed on Friday, 02014.10.31, at $41.47. 52-week range: $29.51 - $74.73.
Wednesday, October 29, 2014
Fast forward to yesterday (02014.10.28)...
Twitter (TWTR) lost almost 10% of its market value yesterday (02014.10.28) after reporting 3Q'14 results. In a nutshell: Twitter met expectations, but said next quarter is going to be a tough one. TWTR closed yesterday at $43.78 leaving our investment only slightly above water. 52-week range: $29.51 - $74.73.
Tuesday, October 28, 2014
Monday, October 27, 2014
GDT::Portfolio update... Illumina (ILMN; genomics) is #1 followed by Google (GOOG/GOOGL; informatics), Cray (CRAY; supercomputing), Facebook (FB; informatics), and iRobot (IRBT; robotics).
Nanosphere (NSPH; molecular diagnostics) tanked and this has been bad news for the GDT::Portfolio. Right now NSPH is at #21 (it should be at #10 or higher).
Geeknet (GKNT; e-commerce) is at #10. Our GKNT investment is currently underwater.
Twitter (TWTR; informatics) is at #11. Twitter Inc. reports 3Q'14 results today (02014.10.27) when the markets close.
Wednesday, September 10, 2014
TWTR closed yesterday (02014.09.09) at $50.61. 52-week range: $29.51 - $74.73.
Monday, September 8, 2014
Thursday, August 28, 2014
YHOO closed yesterday (02014.08.27) at $38.18. 52-week range: $26.82 - $41.72.
Wednesday, August 27, 2014
Tuesday, August 26, 2014
Wednesday, August 20, 2014
Tuesday, August 19, 2014
GKNT closed yesterday (02014.08.18) at $11.51. 52-week range: $11.36 - $20.00.
Thursday, August 7, 2014
"However, our instrument sales fell well short of expectations due to timing of hospital capital budgets and a continued lengthy customer implementation process; therefore, we are lowering guidance to reflect this pace of instrument sales and its associated impact on consumable and total revenue."
NSPH closed yesterday at $1.42. Today it opened at $0.93 and I bought some NSPH at $0.97.
Wednesday, August 6, 2014
"The results for the second quarter reflect record revenue and margin performance," said Steven W. Berglund, Trimble's president and chief executive officer. "Almost all of the revenue growth was organic, which reflects generally improved market conditions outside of agriculture. Although we currently anticipate agriculture to remain a challenging market through the rest of the year, we expect our other markets will more than offset that effect. The construction industry, in particular, is accelerating adoption of our technology as the benefits become better understood."
Two additional items from Trimble's 2Q'14 press release.
1. Operating cash flow in the quarter was $131.2 million. Year-to-date operating cash flow was $214.6 million, an increase of 25 percent over the prior year.
2. Subsequent to the end of the second quarter, Trimble repurchased shares pursuant to a Rule 10b-5(1) plan under its open $100 million authorization. As of close of trading August 4, the company has repurchased approximately 1.37 million shares for a total amount of $43.2 million.
TRMB closed yesterday (02014.08.05) at $31.23. 52-week range: $24.90 - $40.17.
"The Company is postponing its earnings release to allow additional time for the completion and review of accounting for its cost of materials estimate, which is an area of focus for remediation of a material weakness previously reported." -- Hanger press release
HGR right now (6:56am MST) is at $30.40. Previous close $31.75. 52-week range: $28.47 - $40.71.
Friday, August 1, 2014
Also today (02014.08.01), Geeknet announced it had acquired Treehouse Brand Stores.
Miscellaneous tidbit mined from the press release...
"To celebrate our fifteenth anniversary, but more importantly to improve the customer experience, ThinkGeek has launched a major brand refresh campaign including the redesign of our web site," said Katy McCarthy, Chief Executive Officer.
Wednesday, July 30, 2014
"Over the last few months we've been on an incredible run of customer wins in both the U.S. and around the world," said Peter Ungaro, president and CEO of Cray. "These awards, some of them multi-year in nature, reaffirm our belief that we're in a great position to continue to grow, not only in 2014 but also over the coming years. Our products are competitively strong, with each of our development roadmaps being driven by the continuing convergence of supercomputing and big data we're seeing in the market. We believe we're in a great position to capitalize on this exciting market evolution and to continue to build on our market leadership."
Why is CRAY a GDT::Portfolio stock? It's because of the continuing convergence of supercomputing and big data.
Tuesday, July 29, 2014
"Level 3 delivered another quarter of solid revenue and Adjusted EBITDA growth," said Jeff Storey, president and CEO of Level 3. "Our ability to help enterprise customers solve their evolving, global telecommunications needs is a key differentiator in the industry. During the second quarter, we also indicated our intent to acquire tw telecom and the integration planning process is well underway."
LVLT closed yesterday (02014.07.28) at $44.91.
Sunday, July 27, 2014
Amazon.com's 2Q'14 press release started with the following.
Operating cash flow increased 18% to $5.33 billion for the trailing twelve months, compared with $4.53 billion for the trailing twelve months ended June 30, 2013. Free cash flow increased to $1.04 billion for the trailing twelve months, compared with $265 million for the trailing twelve months ended June 30, 2013. Free cash flow for the trailing twelve months ended June 30, 2013, includes cash outflows for purchases of corporate office space and property in Seattle, Washington, of $1.4 billion.
AMZN closed at $324.01 on 02014.07.25. 52-week range: $279.33 - $408.06.
Thursday, July 24, 2014
"We are witnessing tremendous interest in our products, which led to record financial results in the second quarter. With the most extensive sequencing portfolio available, we remain extremely well-positioned to develop and address the large and untapped market opportunities ahead of us." -- Jay Flatley, CEO.
FB closed yesterday (02014.07.23) at $180.64. 52-week range: $72.77 - $184.49. Note: The current 52-week high, which was hit on 2 July 02014, is also ILMN's all-time high.
"We had a good second quarter. Our community has continued to grow, and we see a lot of opportunity ahead as we connect the rest of the world." -- Mark Zuckerberg, Facebook founder and CEO. "
FB closed yesterday (02014.07.23) at $71.29. Pre-market trading today hints that FB might hit a new all-time high today (02014.07.24). 52-week range: $32.75 - $72.59. Note: The 52-week high, which was on 11 March 02014, is all-time high.
Tuesday, July 22, 2014
I thought iRobot had a solid 2Q'14, but IRBT is down almost 10% in early after market trading.
iRobot's press release started with: "I am pleased to report a successful second quarter, with results that met our expectations." Colin Angle, Chairman and CEO of iRobot.
Quoting the company's President & CEO Shai Gozani:
Our NASDAQ listing has been an important factor in our access to capital markets and has provided orderly trading in our stock for investors. We are very pleased with our long association with NASDAQ.
NURO closed yesterday (02014.07.21) at $2.02.
According this graph NURO has decreased by 99.3% in ten years.
Monday, July 21, 2014
Friday, July 18, 2014
Free cash flow was $2.98 billion.
Capital expenditures were $2.65 billion.
Cash at the end of 2Q'14 was $61.20 billion.
"On a worldwide basis, we employed 52,069 full-time employees (48,584 in Google and 3,485 in Motorola Mobile) as of June 30, 2014, compared to 49,829 full-time employees (46,170 in Google and 3,659 in Motorola Mobile) as of March 31, 2014."
GOOG closed on 02014.07.17 at $573.73. 52-week range: $502.80 - $604.83. GOOGL closed on 02014.07.17 at $580.82. 52-week range: $421.91 - $615.05.
I've been tracking Google's quarterly results since 4Q'08.
Thursday, July 17, 2014
Tuesday, July 15, 2014
Two items from the 2Q'14 press release.
"Cash, cash equivalents, and investments in marketable securities were $4.3 billion as of June 30, 2014 compared to $5 billion as of December 31, 2013, a decrease of $0.7 billion."
"During the second quarter of 2014, Yahoo repurchased approximately 21 million shares for $719 million."
I liked the following paragraph from the 2Q'14 press release.
"We are pleased to announce today that we have entered into an amendment to the share repurchase agreement with Alibaba, reducing the number of shares that Yahoo is required to sell at the IPO from 208 million shares to 140 million shares. In addition, we are aware that there has been much discussion around the allocation of the Alibaba IPO proceeds. We would like to take this opportunity to let our investors know that we are committed to return at least half of the after-tax IPO proceeds to shareholders, in line with our overarching commitment to maximizing shareholder value through prudent capital allocation."
YHOO closed today (02014.07.15) at $35.61. 52-week range: $26.73 - $41.72.
Monday, July 14, 2014
Thursday, July 10, 2014
Tuesday, July 8, 2014
Friday, July 4, 2014
Thursday, July 3, 2014
Wednesday, July 2, 2014
STEM closed yesterday (02014.07.01) at $2.00. It opened today at $2.19 and spiked to $2.35. Right now (7:35am MST) STEM is at $2.23. Volume is already 7.15 million vs. a full day average of 2.01 million.
Tuesday, July 1, 2014
YHOO closed yesterday (02014.06.30) at $35.15. Today it had a small gap open at $35.53. YHOO had an intra-day low of $33.02 just a few days earlier on 02014.06.26. 52-week range: $24.82 - $41.72.
YHOO ended 2Q'14 at #10 in the GDT::Portfolio.
Saturday, June 28, 2014
NSPH closed yesterday (02014.06.27) at $1.65. Day range: $1.50 - $1.65. 52-week range: $1.20 - $3.53. Volume was 8.8 million vs. 1.1 million.
Thursday, June 26, 2014
Wednesday, June 25, 2014
Monday (02014.06.23) press release title: "Nanosphere Signs Molecular Diagnostic Supply Agreement With HealthTrust". NSPH spiked to $1.78 before closing at $1.57. Volume: 8.2 million vs. 0.8 million.
Tuesday (yesterday; 02014.06.24) NSPH closed at $1.42, down ~10%. Volume: 2.1 million vs. 0.8 million. Press release title after the market closed yesterday: "Verigene(R) Enteric Pathogens Test Receives FDA Clearance".
Today (02014.06.25) NSPH right now (6:56am MST) is at $1.66, up ~17%. Volume is already at 2.8 million.
[update::02014.06.25] Today NSPH closed up 16% at $1.65. Intra-day high: $1.69. Volume: 7 million vs. 0.8 million. 52-week range: $1.20 - $3.60.
This morning (02014.06.25), in pre-market trading, NURO is down almost 20%. Press release title: "NeuroMetrix Announces $8 Million Preferred Stock Placement".
Tuesday, June 24, 2014
Thursday, June 19, 2014
STEM closed yesterday (02014.06.18) at $1.57. Right now (02014.06.19 at 10:15am EDT) STEM is at $1.86 after spiking to $2.00. Volume has been 9.15 million shares vs. a trailing-3-month daily average of 0.69 million.
Wednesday, June 18, 2014
RHT closed today (02014.06.18) at $53.10. 52-week range: $41.89 - $61.45.
Tuesday, June 17, 2014
STEM closed yesterday (02014.06.16) at $1.54. 52-week range: $1.15 - $1.84.
Monday, June 16, 2014
LVLT closed Friday (02014.06.13) at $44.09. Today's intra-day low (as of 7:46am MST): $41.35. 52-week range: $19.71 - $44.77. Note: LVLT almost spiked to a new 52-week high at the open, but the gain quickly evaporated.
Tuesday, June 10, 2014
Monday, June 9, 2014
Note: With respect to determining the buy price, I multiplied Pi by 0.42 and I picked 42% of Pi because 42 is the "Answer to Life, the Universe, and Everything".
[update::02014.06.09] Headline seen this morning after our sale. "Illumina Is Up 140% In The Past Year, But Can It Illuminate Your Portfolio Going Forward?" at Seeking Alpha
Friday, June 6, 2014
Nanosphere (NSPH) is only few cents above its 52-week low. NSPH has fallen to #17 in the GDT::Portfolio and this really sucks. I am considering buying some more NSPH at $1.30.
Illumina (ILMN) was up almost 7% for the week ending today (02014.06.06) and it is currently at #2 in the GDT::Portfolio. I have an order to sell some ILMN at 54 $Pi ($169.65).
Tuesday, June 3, 2014
Monday, June 2, 2014
Friday, May 30, 2014
Wednesday, May 28, 2014
GDT::Portfolio underwent some modifications while I was road tripping and I will be getting caught up as to what happened.
Tuesday, May 6, 2014
"First quarter proved to be challenging for us on a variety of fronts, but our outlook on the core business remains very positive," commented Vinit Asar, President and Chief Executive Officer. "Like many companies, the harsh winter weather throughout the first quarter significantly impacted our sales and earnings.
Not the way you want to start a quarterly report.
And the following was reported.
"The Company lowered its 2014 full-year adjusted diluted EPS guidance [...] The Company has lowered its projected full year 2014 same center sales growth [...] The Company lowered 2014 full-year net sales guidance [...]"
HGR closed yesterday (02014.05.05) at $33.62. 52-week range: $30.10 - $40.71. HGR hit an intra-day low of $30.31 shortly after the market opened.
Thursday, May 1, 2014
Cray (CRAY) closed down 11.5% yesterday (02014.04.30) after reporting 1Q'14 results. CRAY closed at $28.71. Intra-day low was $28.30. 52-week range: $16.20 - $42.09.
Twitter (TWTR) closed down 8.6% yesterday (02014.04.30) after reporting 1Q'14 results. TWTR closed at $38.97 after hitting a new 52-week low of $37.24. 52-week range: $37.24 - $74.73.
The S&P 500 all-time high is 1,897.28. Yesterday (02014.04.30) the S&P 500 closed at 1,883.95, so 1,900 is well within reach. Just like with the DJIA, the GDT::Portfolio sucks in comparison to what's happening with the S&P 500.
Wednesday, April 30, 2014
Tuesday, April 29, 2014
"We had a very strong first quarter. Revenue growth accelerated on a year over year basis fueled by increased engagement and user growth. We also continue to rapidly increase our reach and scale. With the integration of MoPub, we now reach more than 1 billion iOS and Android users each month, making us one of the largest in-app mobile ad exchanges in the world and the only one at scale to offer native in-app advertising."
Sounds great, but Wall Street doesn't seem to be overly impressed.
TWTR closed on 02014.04.29 at $42.62. 52-week range: $38.80 - $74.73.
Monday, April 28, 2014
Thursday, April 24, 2014
FB closed yesterday (02014.04.23) at $61.36. 52-week range: $22.67 - $72.59. In pre-market trading today (02014.04.24) FB is up almost 4%; however, quoting Facebook Chief Operating Officer Sheryl Sandberg concerning Instagram: "We're very focused on consumer growth, and we move slowly and deliberately in monetization. "We don't see the need or the urge to ramp this as quickly as we possibly can." Hmm... #slowly and #deliberately are not the favorite hashtags for some investors.
Stocks::Stuffer iRobot posting from three weeks ago 02014.04.03...
iRobot (IRBT), after the market closed on 02014.04.02, reported that they had allocated $50 million to buyback IRBT shares over the span of the next year. "The Board's authorization of a share repurchase program reflects our confidence in the health and long-term outlook of the company. With a strong balance sheet and cash flows, we believe we can take advantage of volatile market conditions to buy back our shares while maintaining the flexibility to make strategic investments in our future." -- Colin Angle, iRobot's chairman and CEO
Stocks::Stuffer iRobot posting from yesterday (02014.04.23)...
iRobot (IRBT) reported 1Q'14 results after the market closed yesterday (02014.04.22). I liked iRobot's start to 02014, but IRBT fell 4+% in after hours trading. My guess is Wall Street didn't like CEO Colin Angle saying, "Based on our Q1 results and our outlook for the rest of 2014, we are reaffirming our full-year financial expectations [...]". IRBT closed yesterday (02014.04.22) at $39.65. 52-week range: $26.30 - $48.36.
Wednesday, April 23, 2014
IRBT closed yesterday at $39.65. 52-week range: $26.30 - $48.36.
Tuesday, April 22, 2014
Our first quarter results have set the stage for a strong 2014. We are experiencing an exciting uptake of our new products, including the NextSeq™ 500 and HiSeq X™ Ten, while demand for the overall product portfolio remains robust. We continue to innovate across the entire spectrum of the sequencing workflow to more broadly enable the adoption of genomics." -- Jay Flatley, CEO.
I particularly like the phrase entire spectrum when it comes to genomics.
Illumina's 1Q'14 press release ended with: "For fiscal 2014 the Company has increased projections [...]".
ILMN closed today (02014.04.22) at $141.21. 52-week range: $59.99 - $183.30. ILMN is up 10+% in after hours trading.
Monday, April 21, 2014
Aastrom is acquiring global commercial rights to three marketed autologous cell therapy products. [...] Revenues of those three products were $44 million in 2013. Aastrom will also acquire global manufacturing and production centers located in the United States and Denmark.
Here's a quote from Aastrom's president/CEO: The acquisition of Sanofi's CTRM business is a transformative transaction that positions Aastrom as a fully-integrated global regenerative medicine company." -- Nick Colangelo
ASTM closed last Thursday (02014.04.17; market was closed on Friday) at $3.52. Today (02014.04.21) ASTM opened at $4.00 and spiked to $4.79. Right now (30 minutes into trading) ASTM is at $4.50, up ~28%.
Thursday, April 17, 2014
Here's my summary of Google's 1Q'14 results.
1Q'14 free cash flow was $2.05 billion and this is the lowest its been since 4Q'10. I've been tracking Google's quarterly results since 4Q'08.] Capital expenditures were $2.35 billion, which was a record quarterly high. [During the last 12 months Google's capital expenditures have totaled $850 billion.] Google ended 1Q'14 with $59.38 billion in "cash." During 1Q'14 Google added 2,488 Googlers (i.e. employees). Google's effective tax rate for 1Q'14 was 18%.
GOOG and GOOGL closed 02014.04.16 at $556.54 and $563.90, respectively. In pre-market trading on 02014.04.17, GOOG and GOOGL are down 1.2% and 1.8%, respectively. [Note: Google was down almost 5% after reporting 1Q'14 results.]
Wednesday, April 16, 2014
End of 1Q'14 there were approximately 1,031,420,000 YHOO shares.
Reuters (02014.04.16): "Speculation about the valuation of Alibaba has reached a fever pitch, with some brokerages pegging it as high as $190 billion."
Yahoo! owns approximately 24% of Alibaba.
24% of $190,000,000,000 is $45,600,000,000. $45,600,000,000 divided by 1,031,420,000 YHOO shares is approximately $44.21 per YHOO share.
YHOO closed on 02014.04.15 at $34.21. After reporting 1Q'14 results, YHOO opened on 02014.04.16 at $36.98. YHOO 52-week high: $41.72. I will probably sell some YHOO if it hits 14 $Pi ($43.98).
Tuesday, April 15, 2014
The following are a couple of items I liked from Yahoo!'s 1Q'14 press release.
"Cash, cash equivalents, and investments in marketable securities were $4.6 billion as of March 31, 2014 compared to $5 billion as of December 31, 2013, a decrease of $0.4 billion."
During the first quarter of 2014, Yahoo repurchased 12 million shares for $450 million and used a net $22 million for acquisitions."
YHOO closed today (02014.04.15) at $34.21. 52-week range: $22.70 - $41.72.
Friday, April 11, 2014
Tuesday, April 8, 2014
Monday, April 7, 2014
Friday, April 4, 2014
LVLT took over 14th place moving AMZN to 15th. LVLT made new 52-week highs while AMZN right now is almost 20% below its all-time high. AMZN 52-week range: $245.75 - $408.06. AMZN closed yesterday (02014.04.03) at $333.62.
GOOGL was added to GDT::Portfolio at #6, which pushed AMZN to #16.
GOOG was #2 at the time of the GOOG/GOOGL split. Right now GOOGL is #6 and GOOG is #7.
This was the first time Google executed a stock split and it resulted in a new class of shares that trade under the symbol GOOGL. The next time Google does a stock split they can append an 'E' to GOOGL and get GOOGLE.
GOOG closed at $1,135.10 on Wednesday, 02014.04.02.
GOOG and GOOGL closed yesterday (Thursday, 02014.04.03) at $569.74 and $571.50, respectively.
TWTR closed yesterday (02014.04.03) at $44.05. 52-week range: $38.80 - $74.73.
Thursday, April 3, 2014
IRBT closed yesterday (02014.04.02) at $42.82. 52-week range: $23.76 - $48.36. At $42.82, approximately 1,167,678 shares could be purchased and that's ~4% of the all IRBT shares.
iRobot's buyback announcement resulted in a "sell" order to be executed at 14 $Pi ($43.98).
[02014.04.03] IRBT closed down a nickel today (02014.04.03) at $42.77. Day's range: $42.15 - $44.43. Volume was below the trailing-3-month average.
Wednesday, April 2, 2014
LVLT closed yesterday (02014.04.01) at $40.75 after hitting a new 52-week high of $40.99. Today (02014.04.02) LVLT hit a new 52-week of $41.18.
Tuesday, April 1, 2014
ASTM closed yesterday (02014.03.31) at $4.39.
Saturday, March 29, 2014
I like Red Hat's CEO. I like that Red Hat is a leader when it comes to Open Source. I have grown a liking to Red Hat's FY. I have to sell some RHT at $67.48, but I don't want to.
Thursday, March 27, 2014
"Red Hat continues to deliver a compelling combination of revenue growth, profitability and cash flow."
[...]"We continued to invest in new technologies and commercial capabilities that further expand our future growth opportunities in open hybrid cloud computing".
I like the phrase "open hybrid cloud computing." #OpenHybridCloudComputing
I like Red Hat's use of the word future because for me it's all about the #future.
These days when I look at a Red Hat quarterly results press release, I immediately goto "cash and investments." As of 28 Feb 02014: $1.49 billion.
RHT closed today (02014.03.27) at $56.13. Intra-day low was $54.80. 52-week range: $41.89 - $61.45.
"Don't fall in love with your stocks" is true. I don't love RHT, but I'm sure glad RHT is a GDT::Portfolio stock (it's currently at #6). I'm a long-term thinker of Open Source being a sustainable movement and not a revolution. RHT is a leader in Open Source computing and for a long time I've been calling myself a FLOSSer (i.e. user of Free/Libre Open Source Software). I need to sell some RHT at $67.48, so I'd like to see a near term RHT pop.
[sidebar] I'd like to see Red Hat Inc. switch from fiscal year reporting to calendar year reporting. Still, I like that 02014 is don and we're currently in 1Q'15. To me, 02015 sounds like a futuristic year.
Wednesday, March 26, 2014
At $147.89 ILMN still has a whopping PSR (Price Sales Ratio) of 13.62, but Illumina is a genomics leader and I believe we've only recently entered into the Age of Genomics.
On 02014.03.26 Yahoo! Finance is showing ILMN's SIR (Short Interest Ratio) at 11.6, which I consider high.
Tuesday, March 25, 2014
Yesterday, 02014.03.24, Aastrom Biosciences (ASTM) fell 21.7% after a couple of days of huge gains. Also, yesterday, Nanosphere (NSPH) closed at $2.05 putting that key investment underwater. Two top stocks--Illumina (ILMN) and iRobot (IRBT)--are 18% and 15% from their respective 52-week highs.
#Volatility is the rule.
Friday, March 21, 2014
Today (02014.03.21) ASTM opened at $5.15 (up ~6%) and spiked to $5.30.
ASTM ended 02013 at $3.23.
[update::02014.03.21] ASTM closed today at $6.49, up 30.58%. Intra-day high was $7.00. Volume was 5.36M vs. 0.97M. Note: According to Yahoo! Finance ASTM has a float of approximately 5.73M.
Wednesday, March 19, 2014
"Our core U.S. microbiology business is continuing to grow and we expect our expanding infectious disease test menu to build upon this momentum. This facility provides us with another component in our financing plan that ensures Nanosphere has the capital necessary to take advantage of our growing market opportunities," said Michael McGarrity, President and Chief Executive Officer of Nanosphere.
Nanosphere will be hosting an Investor Day tomorrow (02014.03.20) in New York City.
NSPH closed yesterday 02014.03.18 at $2.29. 52-week range: $1.77 - $4.49.
Tuesday, March 18, 2014
GKNT closed yesterday (02014.03.17) at $13.97. 52-week range: $12.38 - $20.00.
Monday, March 17, 2014
YHOO 52-week range: $21.87 - $41.72.
Wednesday, March 12, 2014
ALTI's volatility has been extremely volatile over the span of the last few weeks. On 02014.02.26, ALTI had an intra-day high of $6.98. Yesterday ALTI had a trading range of $6.93 to $5.18 before closing at $5.29.
One month chart...
I liked the company's comment about 02014.
In 2014, we expect to generate significant cash flow from operations, free cash flow after the interest payments on our Senior Notes, and for our accounts receivable DSOs to continue to decrease. We also expect to refinance Kratos' senior notes in 2014, after the "no call" provision expires at the end of May, with the opportunity to significantly reduce the Company's interest rate and further increase our free cash flow."
KTOS closed yesterday (02014.03.11) at $7.98. 52-week range: $4.14 - $9.18.
Tuesday, March 11, 2014
Monday, March 10, 2014
[original posting on 02014.03.10] Twitter (TWRT) closed Friday, 02014.03.07, at $53.53. 52-week range: $38.80 - $74.73. I want more TWTR in the GDT::Portfolio, so I placed a limit order to buy some TWTR at 17 $Pi ($53.41). I want to buy more TWTR without chasing it, yet I'm chasing it at 17 $Pi.
Friday, March 7, 2014
Kratos Technology & Training Solutions Inc., San Diego, Calif., was awarded a potentially estimated $35,211,430 indefinite-delivery/indefinite-quantity, cost-plus-fixed-fee, multiple-award contract to support Space and Naval Warfare Systems Center Pacific’s Training Development and Support Center to provide training for a range of program offices. This is one of four contracts awarded. Each awardee will have the opportunity to compete for task orders during the ordering period. Work will be performed in San Diego, Calif., and work is expected to be completed March 4, 2017. Fiscal 2014 operations and maintenance, Navy; other procurement, Navy and research, development, test and evaluation funds in the amount of $50,000 will be obligated at the time of award, and will not expire at the end of the current fiscal year. This contract was competitively procured via full and open competition via publication on the Federal Business Opportunities website and the SPAWAR e-Commerce Central website, with seven proposals received and four selected for award. The Space and Naval Warfare Systems Center Pacific, San Diego, Calif., is the contracting activity (N66001-14-D-0106). (Awarded March 5, 2014)
At $8.14, KTOS has a Price Sales Ratio (PSR) of 0.47.
Kratos will be reporting 4Q'13 results after the market closes on Tuesday, March 11th.
At its current price IRBT has a Price Sales Ratio (PSR) of 2.71, which I consider low for a technology company.
Thursday, March 6, 2014
On 02013.01.01 I had a posting titled Spire (SPIR) Needs To Spire Upward in 02013. It didn't happen. SPIR started 02013 at $0.50 and ended 02013 at $0.54. I didn't define "spire upward" to mean an 8% gain.
SPIR is up ~76% so far this year and that fits my definition of "spire upward" a bit better. The GDT::Porfolio needs SPIR to stop being a penny stock. Will SPIR continue to "spire upward" here in 02014? If only I had a crystal ball.
[02014.03.06] SPIR closed on 02014.03.06 at $1.06 after hitting an intra-day high of $1.17.
Wednesday, March 5, 2014
[update::02014.03.05] "JPMorgan has upgraded Trimble Navigation (TRMB_) to "overweight" from "neutral" with a $43 price target." via TheStreet.com. TRMB closed yesterday (02014.03.04) at $38.99.
Monday, March 3, 2014
Friday, February 28, 2014
Tuesday, February 25, 2014
[update::02014.02.26] 30 minutes into trading today and ALTI is up 12% of heavy volume (487,000 vs. 33,100). ALTI is at $6.53 after hitting an intra-day early morning high of $6.94. If there's news (and I suspect there is), I'm not aware of it.
[update::02014.02.27] ALTI closed yesterday (02014.02.26) at $5.98, up only 2.57%. Intra-day high was $6.98. Volume was 770,889, which according to the information I see on Yahoo! Finance is ~16% of the float. Again, if there's news, I don't know that it is.
Monday, February 24, 2014
This morning Illumia issued a press release that started with the following paragraph.
Science for Life Laboratory (SciLifeLab) in Sweden has joined the Illumina Genome Network (IGN) to provide researchers with broader access to Illumina’s whole genome sequencing technology. SciLifeLab is the first IGN partner in Europe and will initiate a national large-scale population sequencing program seeking to identify genetic causes of human diseases.
Friday, February 21, 2014
At $10.18 our GKNT investment will be underwater. The question I'm asking myself right now: At what price might be a good price to buy some GKNT?
[update::02014.02.22] GKNT closed yesterday (02014.02.21) at $14.47, which means the company lost ~16% of its market value. Volume was 225,449; however, GKNT is a thinly traded stock that had a trailing-3-month average of 11,974. Approximately 3% of GKNT shares were traded.
Thursday, February 20, 2014
Bruker (BRKR) get a 'Sell' rating by Zacks Equity Research. Zachs.com has a posting headlined: Can Bruker (BRKR) Continue to Rise? My response: Yes... as long as scientists keep doing science.
Geeknet (GKNT) is reporting 4Q'13 results tomorrow (02014.02.21) morning. It bothers me that the company has taken so long to report year end results for 02013. The company has been quiet with respect to ThinkGeek's holiday sales.
Wednesday, February 19, 2014
Looking ahead to 2014, we feel better about the health of our core academic and government customers and about our prospects in the clinical research and diagnostics markets, but we remain cautious about demand from the industrial markets. Overall, we expect to generate year-over-year revenue growth of approximately 3 to 4 percent, and non-GAAP EPS growth of 10 to 14 percent, for the full year 2014.BRKR closed yesterday (02014.02.18) at $21.86. 52-week range: $15.41 - $22.25. At its current price BRKR has a PSR (Price Sales Ratio) of 2, which I think is low for a company that makes equipment that scientists use to create our future.
Five minutes into trading today (02014.02.19) BRKR is at $23.25 (up ~6.4%) after spiking to a new 52-week high of $23.59.
Tuesday, February 18, 2014
I need my head examined, but I bought some VeriTeQ (VTEQ) today (02014.01.10) at $0.83. Just a few days ago VTEQ was a $2 stock. Back on 22 October 02013 VeriTeQ (formerly Digital Angel [DIGA]) executed a 1:30 (reverse) stock split.
Today, 02014.01.18, VTEQ closed at $1.39, up 33.65%. 52-week range: $0.60 - $4.30. The company issued a press release having the following headline: VeriTeQ Partner Establishment Labs Receives Additional CE Mark Approvals to Market Breast Implants with Q Inside Safety Technology. The sub-headline was: New CE Mark Approvals Permit the Sale of Motiva Implants with Q Inside Safety Technology to 28 Countries in the European Union
I've always found RFID an interesting technology.
VeriTeQ develops innovative, proprietary RFID technologies for implantable medical device identification, and dosimeter technologies for use in radiation therapy treatment. VeriTeQ offers the world's first FDA cleared RFID microchip technology that can be used to identify implantable medical devices, in vivo, on demand, at the point of care.
VTEQ is a crap shoot.
Friday, February 14, 2014
"We had a great year in 2013, led by strong growth in both supercomputing and big data," said Peter Ungaro, president and CEO of Cray. "We set Company records for annual and quarterly revenue as we completed the acceptance of more supercomputers during the fourth quarter than we have in any quarter in our history.
Thursday, February 13, 2014
Today (02014.02.13), prior to the markets opening, I saw this news: Nanosphere upgraded to Buy from Neutral at Roth Capital Roth Capital upgraded Nanosphere citing improved revenue and placement visibility following the company's Q4 results. Roth raised its price target for shares to $3 from $2.50.
NSPH is a speculative investment. From Nanosphere's 4Q'13 press release: Cash flow for the fourth quarter of 2013 was negative $7.8 million as compared with negative $8.8 million in the same quarter of 2012. Cash at December 31, 2013 was $41.5 million. Since 02011 the number of NSPH common shares outstanding has increased to ~62,134,000 from ~37,800,000.
Wednesday, February 12, 2014
"While the fourth quarter supports the anticipation of an improved organic growth outlook for 2014, the environment continues to be comparatively uncertain with variations of regional economic performance, continuing deferrals of investment, and continued constrained government funding."
Tuesday, February 11, 2014
At $21.74, BRKR has a PSR (Price Sales Ratio) of 2, which I think is low given Bruker is the maker of scientific equipment that is helping researchers create our future.
Saturday, February 8, 2014
GOOG closed yesterday (02014.02.07) at $1177.44. 52-week range: $761.26 - $1186.54.
Thursday, February 6, 2014
Wednesday, February 5, 2014
Twitter's revenue for 02013 was $665 million. The company is projecting 02014 revenues of $1.15 billion to $1.2 billion.
Twitter ended 02013 with approximately $2.2 billion in "cash."
TWTR closed today (02014.02.05) at $65.97. 52-week range: $38.80 - $74.73.
[update::02014.02.06] Ouch! TWTR opened down 23.28%. Previous close $65.97; opened at $50.61. Dipped to $50.00 and right now (35 minutes into trading) its down 19% at $53.35.
LVLT had a gap open today (02014.02.05). Previous close was $31.41 and the open was at $32.59. LVLT spiked to a new 52-week high $34.83 during the first few minutes of trading.
Monday, February 3, 2014
KTOS closed Friday, 02014.01.31, at $7.23. 52-week range: $4.08 - $9.16.
[update::02014.02.03] Markets opened while I was typing this in. Two minutes into trading and KTOS was at $9.02 (up 24.70%).
Friday, January 31, 2014
During the last three months of 02013 Google had free cash flow of $2.98 billion while spending $2.26 billion on capital expenditures ("the majority of which was for production equipment, data-center construction, and real estate purchases"). In addition, during the last three months of 02013, Google hired 1,520 full-time workers. Google Inc. started 02013 with $48.1 billion in "cash" and 12 months later the cash increased to $58.7 billion. In a nutshell: It appears as though Google had a decent 02013.
GOOG closed yesterday (02014.01.30) at $1,135.39. Today GOOG had a gap open at $1,171.35 and it spiked to a new 52-week/all-time high of $1,172.00. Right now (7:44am MST) GOOG is at $1661.00 (up ~2.3%) even though the DJIA is down 1.33%, S&P 500 is down 1.13%, and NASDAQ is down 0.98%.
For the full year of 02013, Google had free cash flow of $11.29 billion and capital expenditures of $7.35 billion. Google's cash position increased by $10.62 billion during 02013. In addition, the number of Googlers (i.e. Google employees that don't work for Motorola) increased from 37,544 to 43,682 (approximately 16.8 new hires per day) during 02013.
Wednesday, January 29, 2014
"It was a great end to the year for Facebook. We're looking forward to our next decade and to helping connect the rest of the world." -- Mark Zuckerberg, Facebook founder and CEO
Facebook ended 02013 with approximately $11.45 billion in "cash." I liked the following from the press release: "Free cash flow for the full year of 2013 was $2.85 billion." And... "Capital expenditures for the fourth quarter of 2013 were $483 million."
FB closed today (02014.01.29) at $53.53. 52-week range: $22.67 - $59.31. 20 minutes after the release of 4Q'13 results, FB is up almost 7%.
"The fourth quarter capped off a spectacular year for Illumina with robust performance across all products and geographies. We made significant progress on key R&D programs which allowed us to introduce new products in early 2014 that will once again redefine the trajectory of sequencing. We plan to leverage this momentum in 2014 to more broadly enable the adoption of genomics." -- Jay Flatley, CEO
I continue to believe that we have entered the Genomics Age and Illumina is a solid genomics company.
From today (02014.01.29): "Mizuho raised its price target for Illumina shares to $175 citing the company's strong preannounced Q4 results and reiterates a Buy rating on the stock." I don't who Mizuho is, but I'd like to see ILMN at $175.
ILMN closed yesterday (02014.01.28) at $144.53. Today it hit a new 52-week high of $154.92. 52-week range: $48.00 - $154.92.
Tuesday, January 28, 2014
One item that I liked from the 4Q'13 press release.
During the fourth quarter of 2013, Yahoo repurchased 6 million shares for $231 million and used a net $60 million for acquisitions. During the year ended December 31, 2013, Yahoo repurchased 129 million shares for $3.3 billion and used a net $1.2 billion for acquisitions.
Yahoo! ended 02013 with $5 billion in cash.
YHOO closed on 02014.01.28 at $38.22. 52-week range: $19.31 - $41.72.
[02014.01.29] YHOO closed today at $34.89, down almost 9%, on heavy volume. 52-week range: $19.31 - $41.72. In a nutshell: Investors are not happy with Yahoo!'s growth prospects.
Monday, January 27, 2014
Saturday, January 25, 2014
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced an important addition to its intellectual property with receipt of a Notice of Allowance of patent claims supporting its cancer immunotherapy portfolio in the United States. Notice of Allowance is the final step in the issuance of a patent. The company believes that this patent will significantly strengthen Adamis' cancer immunotherapy patent portfolio and will further support its TeloB-VAX vaccine technology.
ADMP had a gap opening yesterday (02014.01.24) at $7.02 (previous close was $6.80). It spiked to $7.25 before falling to a close of $6.68 (down almost 2% for the day). Volume was 6-time trailing-3-month average. 52-week range: $3.40 - $17.17.
Wednesday, January 22, 2014
IBM's 4Q'13 did not meet Wall Street's expectations and right now, in pre-market trading on 02014.01.22, IBM is down 3.6%. IBM closed yesterday (02014.01.21) at $190.09. 52-week range: $172.57 - $215.90.
I found the following interesting.
"We continued to drive strong results across much of our portfolio and again grew earnings per share in 2013. While we made solid progress in businesses that are powering our future, in view of the company’s overall full year results, my senior team and I have recommended that we forgo our personal annual incentive payments for 2013." -- Ginni Rometty, IBM chairman, president and chief executive officer
IBM ended 02013 with "$11.1 billion of cash on hand and generated free cash flow of $15.0 billion excluding Global Financing receivables, down approximately $3.2 billion year over year. The company returned $17.9 billion to shareholders through $4.1 billion in dividends and $13.9 billion of gross share repurchases."
Tuesday, January 21, 2014
Dr. Nakamura’s position in the Japan medical profession and understanding of local medical practice will be a valuable near-term source of advice and guidance as we move toward the launch of NC-stat DPNCheck in the Japanese market during 2014.
The NeuroMetrix press release stated: "Dr. Nakamura is considered a leader in the field of diabetes research and treatment." I find this believable; consequently, I find it difficult to believe Dr. Nakamura would become associated with a losing company.
NURO closed on 02014.01.17 at $2.61. 52-week range: $1.47 - $4.25.
Thursday, January 16, 2014
At the start of the year I spent time in a spot where there were a bunch of people my age jogging/running. I was walking, so I kept getting passed by these people. While walking I found myself saying over and over... don't sell anymore Hanger.
Wednesday, January 15, 2014
Rewind to Stocks::Stuffer posting one 02012.03.29 titled: "Illumina Needs to Say no, nO, NO!". Here's the second paragraph from that posting.
Illumina (ILMN) closed yesterday (02012.03.28) at $49.88. 52-week range: $25.57 - $79.40. Roche's initial offer was $44.50 and their new offer is $51. I don't want sell our ILMN shares at $51 because I think they are worth more than that; therefore, this is potentially bad news because other investors might disagree with my opinion and be happy cashing out at $51. I continue to believe Roche is trying to buy Illumina on the cheap.
Yesterday (02014.01.14) Illumina issued a press release that started with the following.
Illumina, Inc. (ILMN) today broke the ‘sound barrier’ of human genomics by enabling the $1,000 genome. This achievement is made possible by the new HiSeq X Ten Sequencing System. This platform includes dramatic technology breakthroughs that enable researchers to undertake studies of unprecedented scale by providing the throughput to sequence tens of thousands of human whole genomes in a single year in a single lab.
I continue to believe that we have entered into the Age of Genomics.
Sunday, January 12, 2014
Friday, January 10, 2014
Tuesday, January 7, 2014
Monday, January 6, 2014
Today (02014.01.06) Zacks Equity Research rated ASTM a "strong buy". ASTM is up almost 18% since the end of 02013.
Today (02014.01.06) StemCells Inc. posted a "Letter to Shareholders". The following is the first paragraph from the letter.
Every day, the news media brings us word of some new advancement in the development of stem cell therapies. While you clearly comprehend the vast potential of stem cell therapeutics to transform the practice of medicine, it can be understandably difficult to assess which companies to bank on amidst so much hoopla and hyperbole. As CEO, one of my easiest and most gratifying jobs is to report our persistent progress to you — real evidence that StemCells, Inc. continues to be a clear frontrunner.
The second paragraph started with the following sentence.
What is more difficult is trying to understand our Company's stock performance for the year just ended.
STEM is up almost 12% since the end of 02013.